http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009197831-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9923b963b8001b3884fd9e740271c092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bfc39ded49ab793928c5e0343866ad9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2788fe181442837ed62ba80366ad4648
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 2005-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13444a8f3f198b85acf14d25637a9851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1a72ad9690b6119a7f82bfd60becd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b7c15cb9412f4386fef383d2b3e6c1e
publicationDate 2009-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009197831-A1
titleOfInvention Composition for the Treatment of Obesity and Hyperlipidemia
abstract Current invention is related to the pharmaceutical industry in general and to the industry of the manufacture of pharmaceutical products for weight reduction and hyperlipidemia treatment. The advantages of the current invention respect of the similar of the state of the art are that in the present invention side effects normally produced by the consumption of lipase inhibitors are eliminated; optimizing both the lipase inhibitor component and the fat-trapping; with the adequate composition of each one of the components and with very small amounts of each one. The invention consists of a composition for the treatment of the obesity and hyperlipidemia, characterized by comprising in combination a lipase inhibitor and a fat-trapping component.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012244236-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101292935-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9399043-B2
priorityDate 2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6030953-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128847057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9805651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127407306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226485926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54164148

Total number of triples: 33.